🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical study is to evaluate the safety and efficacy of hylan G-F 20 ...
Status
Completed
Location
Hopital Erasme
Start Date
2005-05
Trial ID
NCT00131352
Treatments Being Tested
Malaria is a disease that affects many people in Africa. Malaria is caused ...
Status
Completed
Location
University of Bamako, Malaria Research and Training Center
Start Date
2007-05
Trial ID
NCT00460525
Treatments Being Tested
The goal of the study is to investigate the safety, tolerability and effica...
Status
Recruiting
Location
Save Sight Institute
Start Date
2025-08-29
Trial ID
NCT06628947
Treatments Being Tested
The primary objective of the study was to investigate the safety and tolera...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00224783
This is a randomized, double-blinded, Phase II study in healthy males and n...
Status
Completed
Location
The Hope Clinic of Emory University
Start Date
2018-02-14
Trial ID
NCT03312231
Treatments Being Tested
This study will enroll volunteers in an open-format (outside hospital) sett...
Status
Completed
Location
Texas A&M University - CTRAL
Start Date
2022-02-08
Trial ID
NCT05346302
Treatments Being Tested
The objectives of this study are to explore the safety and efficacy of subc...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02035267
Treatments Being Tested
The purpose of this study is to see if two new malaria vaccines called FMP1...
Status
Completed
Location
WRAIR Clinical Trials Center
Start Date
2001-04
Trial ID
NCT01556945
Treatments Being Tested
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Status
Unknown
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Start Date
2018-09-25
Trial ID
NCT02858570
Treatments Being Tested